News | April 07, 2022
BIO KOREA, Asia's Biggest Bio-Health Convention, to open in May 2022
Global event to kick off as the post-covid era begins in earnest, with theme "beyond the pandemic, into a next wave"
Global event to kick off as the post-covid era begins in earnest, with theme "beyond the pandemic, into a next wave"
Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23
An integrated and agile approach enables the pharmaceutical CDMO industry to simplify manufacturing as it moves from primary care medicines to specialty medicines
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
Iktos and Teijin Pharma will collaborate in developing new AI technology aiming to bring further improvement and speed to the drug design process
Highlighted as game changer in drug development & delivery special feature on innovative technologies for improving drug solubility and bioavailability
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
The launch of medical cannabis products resulted from an agreement between the two companies signed in 2021
The plant is scheduled to come on stream in September 2024
The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
